Limit search to available items
Book Cover

Title Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs ; Forum on Drug Discovery, Development, and Translation ; Board on Health Sciences Policy, Institute of Medicine of the National Academies
Published Washington, D.C. : National Academies Press, ©2012


Description 1 online resource (xvi, 232 pages) : illustrations (some color)
Series Online access: National Academy of Sciences National Academies Press
Online access: NCBI NCBI Bookshelf
Contents Introduction -- Integrating community practice and clinical trials -- Improving public participation in clinical trials -- Creating a new business model for clinical trials -- Building an infrastructure to support clinical trials -- Suggesting an agenda for transforming elements of the clinical trials enterprise
Summary "There is growing recognition that the United States' clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions. With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, and Translation held a two-day workshop in November 2011, bringing together leaders in research and health care. The workshop focused on how to transform the CTE and discussed a vision to make the enterprise more efficient, effective, and fully integrated into the health care system. Key issue areas addressed at the workshop included: the development of a robust clinical trials workforce, the alignment of cultural and financial incentives for clinical trials, and the creation of a sustainable infrastructure to support a transformed CTE. This document summarizes the workshop"--Publisher's description
Bibliography Includes bibliographical references
Notes Print version record
Subject Clinical trials -- United States
Clinical trials -- Economic aspects -- United States
Clinical trials -- Social aspects -- United States
Drug development -- United States
Drugs -- Testing.
Pharmaceutical industry -- United States
Business and medicine -- United States
Drugs -- Design.
Pharmaceutical industry.
Randomized Controlled Trials as Topic -- United States -- Congresses
Clinical Trials as Topic -- United States -- Congresses
Drug Design -- United States -- Congresses
Drug Industry -- United States -- Congresses
Clinical Trials as Topic
Drug Design
Randomized Controlled Trials as Topic
Drug Industry
Drugs -- Design
Pharmaceutical industry
Drugs -- Testing
Drug development
Business and medicine
Clinical trials
United States
United States
Genre/Form proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congrès.
Form Electronic book
Author Weisfeld, Neil E
English, Rebecca A
Claiborne, Anne B
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Institute of Medicine (U.S.). Board on Health Sciences Policy
LC no. 2012474101
ISBN 9780309253154